Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 57
dc.coverage.spatialGinebraen
dc.date.accessioned2012-03-04T21:15:08Z
dc.date.available2012-03-04T21:15:08Z
dc.date.issued2004
dc.identifier.govdocA57/15
dc.identifier.urihttp://www.who.int/iris/handle/10665/21235
dc.description3 p.en
dc.description57ª Asamblea Mundial de la Salud, punto 12.12 del orden del día provisionalen
dc.language.isoesen
dc.publisherOrganización Mundial de la Saluden
dc.subjectPharmaceutical productsen
dc.subjectBlood safetyen
dc.subject.meshDrug Industryen
dc.subject.meshDrug Monitoringen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshBlooden
dc.subject.meshBlood Substitutesen
dc.subject.meshCommerceen
dc.subject.meshInterinstitutional Relationsen
dc.titleCalidad y seguridad de los medicamentos: sistemas de reglamentación: informe de la Secretaríaen
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifierlegislation and jurisprudenceen
who.relation.languageVersion10665/22902en
who.relation.languageVersion10665/20909en
who.relation.languageVersion10665/20750en
who.relation.languageVersion10665/20091en
who.relation.languageVersion10665/22413en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record